NHS Logo
Image from Google Jackets

Gene therapy for cardiovascular diseases and arrhythmia [E-Book]

Contributor(s): Series: Cardiology research and clinical developments seriesPublisher: New York : Nova Biomedical, [2012]Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781619427549
  • 1619427540
Subject(s): Online resources:
Contents:
GENE THERAPY FOR CARDIOVASCULAR DISEASES AND ARRHYTHMIA; GENE THERAPY FOR CARDIOVASCULAR DISEASES AND ARRHYTHMIA; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Introduction; Chapter I: General Principles of Gene Transfer; 1.1. Viral and Non-viral Gene Delivery; 1.2. Adenovirus; 1.3. Adeno-Associated Virus (AAV); 1.4. Retroviruses; 1.5. Lentivirus; 1.6. Naked DNA; References; Chapter II: Gene Delivery Techniques; 2.1. Current Cardiac Gene Delivery Techniques; 2.2. Direct Gene Delivery; 2.3. Intracoronary Infusion; References.
Chapter III: Gene Therapy for Coronary Artery and IschemicHeart Disease3.1. Coronary Artery and Ischemic Heart Disease; 3.2. Gene Therapy for Coronary Atherosclerosis; 3.3. Gene Therapy for Angiogenesis in Ischemia; 3.4. Gene Therapy for Myocardial Reperfusion Injury; References; Chapter IV: Gene Therapy for Heart Failure; References; Chapter V: Viral Gene Therapy in Myocarditis; 5.1. Myocarditis, at the Bedside; 5.2. Myocarditis, at the Bench; 5.2.1. Experimental Animal Models and Pathophysiology; 5.2.2. Experimental Viral Myocarditis; 5.2.3. Experimental Autoimmune Myocarditis.
5.2.4. Virus-Associated Gene Transfer5.3. Study Limitations and Open Questions; References; Chapter VI: Gene Therapy for Atrial Arrhythmia: A Therapeutic Approach for Atrial Fibrillation; References; Chapter VII: Gene Therapy for Ventricular Arrhythmia; References; Chapter VIII: Stem Cell Therapy for Cardiovascular Disease; 8.1. Promises and Limitations of Different Cell Populations; 8.1.1. General Aspects; 8.1.2. Differentiation Potential; 8.1.3. Cell Sources in Detail (for Summary Refer to Table 1); 8.1.3.1. Bone Marrow Mononuclear Cells; 8.1.3.2. Mesenchymal Stem Cells.
8.1.3.3. CD133+ Progenitor Cells8.1.3.4. CD34+ Progenitor Cells; 8.1.3.5. Myoblasts; 8.1.3.6. Resident Myocardial Progenitor Cells; 8.1.3.7. Embryonic Stem Cells; 8.1.3.8. Induced Pluripotent Stem Cells; 8.2. Stem Cell Delivery; 8.2.1. Intravenous Administration; 8.2.2. Myocardial Injection; 8.2.3. Intracoronary Delivery; 8.3. Cytokine Therapy; 8.4. Mechanisms of Cell-Based Therapy; 8.4.1. Stem Cell Homing; 8.4.2. Stem Cell Migration within the Myocardium; 8.4.3. Precommitment Versus in Vivo Differentiation; 8.4.4. Transdifferentiation versus Cell Fusion.
8.4.5. Paracrine Effects of Stem Cell Therapy8.5. Stem Cell versus Gene Therapy; 8.6. Future Directions of Cardiovascular Cell-Therapy; 8.6.1. Priming of Stem Cells; 8.6.2. Bionanotechnology to Restore Extracellular Matrix; 8.6.3. Tissue Engineering; References; Chapter IX: Gene Transfer for the Development of a Biological Pacemaker; 9.1. Anatomy and Physiology of the Human Pacemaker; 9.1.1. Anatomic Basis of the Pacemaker; 9.1.2. Differences in the Action Potential between Pacemaker and Non-Pacemaker Cells; 9.1.2.1. Ventricular Myocyte (Non-Pacemaker Cell) Action Potentials.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library (Kingston Hospital) Online Link to resource Available

Includes index.

Description based on print version record.

GENE THERAPY FOR CARDIOVASCULAR DISEASES AND ARRHYTHMIA; GENE THERAPY FOR CARDIOVASCULAR DISEASES AND ARRHYTHMIA; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Introduction; Chapter I: General Principles of Gene Transfer; 1.1. Viral and Non-viral Gene Delivery; 1.2. Adenovirus; 1.3. Adeno-Associated Virus (AAV); 1.4. Retroviruses; 1.5. Lentivirus; 1.6. Naked DNA; References; Chapter II: Gene Delivery Techniques; 2.1. Current Cardiac Gene Delivery Techniques; 2.2. Direct Gene Delivery; 2.3. Intracoronary Infusion; References.

Chapter III: Gene Therapy for Coronary Artery and IschemicHeart Disease3.1. Coronary Artery and Ischemic Heart Disease; 3.2. Gene Therapy for Coronary Atherosclerosis; 3.3. Gene Therapy for Angiogenesis in Ischemia; 3.4. Gene Therapy for Myocardial Reperfusion Injury; References; Chapter IV: Gene Therapy for Heart Failure; References; Chapter V: Viral Gene Therapy in Myocarditis; 5.1. Myocarditis, at the Bedside; 5.2. Myocarditis, at the Bench; 5.2.1. Experimental Animal Models and Pathophysiology; 5.2.2. Experimental Viral Myocarditis; 5.2.3. Experimental Autoimmune Myocarditis.

5.2.4. Virus-Associated Gene Transfer5.3. Study Limitations and Open Questions; References; Chapter VI: Gene Therapy for Atrial Arrhythmia: A Therapeutic Approach for Atrial Fibrillation; References; Chapter VII: Gene Therapy for Ventricular Arrhythmia; References; Chapter VIII: Stem Cell Therapy for Cardiovascular Disease; 8.1. Promises and Limitations of Different Cell Populations; 8.1.1. General Aspects; 8.1.2. Differentiation Potential; 8.1.3. Cell Sources in Detail (for Summary Refer to Table 1); 8.1.3.1. Bone Marrow Mononuclear Cells; 8.1.3.2. Mesenchymal Stem Cells.

8.1.3.3. CD133+ Progenitor Cells8.1.3.4. CD34+ Progenitor Cells; 8.1.3.5. Myoblasts; 8.1.3.6. Resident Myocardial Progenitor Cells; 8.1.3.7. Embryonic Stem Cells; 8.1.3.8. Induced Pluripotent Stem Cells; 8.2. Stem Cell Delivery; 8.2.1. Intravenous Administration; 8.2.2. Myocardial Injection; 8.2.3. Intracoronary Delivery; 8.3. Cytokine Therapy; 8.4. Mechanisms of Cell-Based Therapy; 8.4.1. Stem Cell Homing; 8.4.2. Stem Cell Migration within the Myocardium; 8.4.3. Precommitment Versus in Vivo Differentiation; 8.4.4. Transdifferentiation versus Cell Fusion.

8.4.5. Paracrine Effects of Stem Cell Therapy8.5. Stem Cell versus Gene Therapy; 8.6. Future Directions of Cardiovascular Cell-Therapy; 8.6.1. Priming of Stem Cells; 8.6.2. Bionanotechnology to Restore Extracellular Matrix; 8.6.3. Tissue Engineering; References; Chapter IX: Gene Transfer for the Development of a Biological Pacemaker; 9.1. Anatomy and Physiology of the Human Pacemaker; 9.1.1. Anatomic Basis of the Pacemaker; 9.1.2. Differences in the Action Potential between Pacemaker and Non-Pacemaker Cells; 9.1.2.1. Ventricular Myocyte (Non-Pacemaker Cell) Action Potentials.

Master record variable field(s) change: 050

There are no comments on this title.

to post a comment.
London Health Libraries Consortium Privacy notice and Membership terms and conditions